0

Ibrutinib Versus Temsirolimus: 3-year Follow-Up of Patients With Previously Treated Mantle Cell Lymphoma From the Phase 3, International, Randomized, Open-Label RAY Study

S Rule, W Jurczak, M Jerkeman, C Rusconi, M Trneny, F Offner, D Caballero, C Joao, M Witzens-Harig, G Hess, I Bence-Bruckler, S-G Cho, C Thieblemont, W Zhou, T Henninger, J Goldberg, J Vermeulen, M Dreyling

Leukemia. 2018 Aug;32(8):1799-1803.

PMID: 29572505

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP162635043 Temsirolimus Temsirolimus 162635-04-3 Price
qrcode